Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes

Leukemia

Volumn 11, Issue 7, 1997, Pages 1055-1062

  Linke, B ^a   Bolz, I ^a   Fayyazi, A ^b   Von Hofen, M ^a   Pott, Ch ^a   Bertram, J ^c   Hiddemann, W ^a   Kneba, M ^a  

^a Department of Internal Medicine   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c NONE

Author keywords

Gene scanning; IgH CDR3; Lymphoma; PCR; Sequencing

Indexed keywords

DNA; DNA POLYMERASE; FLUORESCENT DYE; IMMUNOGLOBULIN HEAVY CHAIN; PRIMER DNA;

ARTICLE; AUTOANALYSIS; B CELL LEUKEMIA; B CELL LYMPHOMA; CELL CLONE; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE ANALYSIS; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOMA; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIPLE MYELOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030825381     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400736     Document Type: Article

References (14)

1. Tonegavva S. Somatic generation of antibody diversity. Nature 1983; 302: 575.
2. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol 1991; 147: 1720.
3. Stewart AK, Schwartz RS. Immunoglobulin V regions and the B cell. Blood 1994; 83: 1717.
4. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human immunoglobulin locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583.
5. Ichihara Y, Matsuoka H, Kurosawa Y. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 1988; 7: 4141.
6. Yamada M, Hudson S, Tournay O, Bittenbender S, Shane SS, Lange B, Tsujimoto Y, Caton AJ, Rovera G. Detection of minimal disease in hematopoietic malignances of the B cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci USA 1989; 86: 5123.
7. Kiyoi H, Naoe T, Horibe K, Ohno R. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells. J Clin Invest 1992; 89: 739.
8. Steward CG, Potter MN, Oakhill A. Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease. Leukemia 1992; 6: 1213.
9. Steenbergen EJ, Verhagen OJ, van Leeuwen EF, von dem Borne AE, van der School CE. Distinct ongoing lg heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood 1993; 82: 581.
10. Kitchingman GR. Immunoglobulin heavy chain gene VHD junctional diversity at diagnosis in patients with acute lymphoblastic leukemia. Blood 1993; 81: 775.
11. Trainor KJ, Brisco MJ, Story CJ, Morley AA. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220.
12. McCarthy KP, Sloan JP, Wiedemann LM. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 1990; 43: 429.
13. Potter MN, Cross NC, van Dongen JJ, Saglio G, Oakhill A, Bartram CR, Goldman JM. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia 1993; 7: 1302.
14. Campana D, Ching-Hon P. Detection of minimal residual disease in acute luekemia: methodologic advances and clinical significance. Blood 1995; 85: 1416.